Welcure Drugs & Pharma Shares Locks 5% Upper Circuit On Declaring Q1FY26 Results

The share price of Welcure Drugs & Pharmaceuticals had a notable gain on Wednesday, reaching its 5% upper circuit limit today. This boost comes after the company reported strong financial performance for the June 2025 quarter. The share price of Welcure Drugs & Pharmaceuticals is now at Rs 10.61 after reaching its day's 5% upper circuit. Compared to its previous closing price of Rs 10.11, this is a notable advancement of 4.95%. The market value of the firm is around Rs 114 crore. The share has fluctuated between a low of Rs 6.40 and a high of Rs 15.89 during the last 52 weeks.

The company's remarkable performance in the first quarter of FY26 contributed to the stock price increase, reporting a revenue of Rs 299.91 Crore in June 2025, marking a 1300% increase from Rs 21.21 Crore in the previous quarter or Q4FY25. In Q1FY26, the firm recorded a net profit of Rs 23.29 crores, compared to a net loss of Rs 0.34 crores in Q1FY25 of the previous year. In comparison to the net profit of Rs 2.5 crore recorded in Q4FY25, which concluded on March 31, 2025, the firm reported an over 830% growth in net profit on a Q-o-Q basis. In Q1FY26, earnings per share (EPS) were Rs 2.07, up from Rs -0.26 in Q1FY25.

The management of the company said, "The strong financial performance in Q1FY26, is a reflection of our business strategies, meticulous decisions and our focused transition to a fee-based, asset-light model. We are committed to sustaining this performance through efficient supply chain management and product diversification."

The company, which only serves as a procurement agent for foreign customers, recently accomplished seven export-sourcing tasks totalling Rs 299.91 crores. The company maintains its debt-free structure by earning a constant 5% commission on these transactions and without exposure to working capital, inventory, or logistical concerns. Welcure's revenue profile has been much improved by this move to fee-based export services; commission income is now recorded on a receipt basis in compliance with Ind AS 115.

Welcure Drugs & Pharmaceuticals Ltd. is a well-known pharmaceutical firm in India that was founded in 1992 and produces and sells a variety of pharmaceutical formulations.